Gaston, R.

transplantation patient mpa exposure exposure transplant study rejection mycophenolate kidney recipient mycophenolate mofetil trial response mofetil t cells monitoring mycophenolic mpa auc relationship memory 60 mg ·h immunosuppression level transplant recipients graft pharmacokinetic concentration mycophenolic acid inhibitor kidney transplantation group tacrolimu dosing regimen drug monitoring effect agent 30 mg ·h enteric-coated mycophenolate sodium van gelder t therapy function complement event withdrawal injury research university kidney transplant patients t effector cells transplant patients toxicity variability organ trough blockade mycophenolic acid exposure effector memory t cells analysis apomygre efficacy period ec-mp gelder novel month immunity allograft recipients target costimulation meeting approach immunologic sampling mpa tdm allograft department outcome foxp 3+ tregs